콘텐츠로 건너뛰기
Merck
  • Augmentation of macrophage antitumor activities and nitric oxide production by oregonin.

Augmentation of macrophage antitumor activities and nitric oxide production by oregonin.

Archives of pharmacal research (2002-09-07)
Seong-Soo Joo, Han-Jun Kim, Hee-Seung Kwon, Do-Ik Lee
초록

Oregonin, a diarylheptanoid derivative from Alnus hirsuta Turcz, Betulaceae, was evaluated for its antitumor activity. Oregonin, known to have an antitumor function, and is a novel immunomodulator, which may augment macrophage activity. MTT assays and NO production tests were performed in order to investigate the cytotoxicity of oregonin in tumor cells and to examine its influence on macrophage in detail. In this study, the tumoricidal activity was also evaluated by a MTT assay. The cytotoxicity measurements in the oregonin-treated group both in vitro and in vivo showed a significant difference from that of the control group. In vivo, oregonin significantly increased NO production in a dose-dependent manner, and in vitro, the thioglycolate-induced inflammatory macrophages increased NO production in a dose-dependent manner after incubation. These results suggest that oregonin reacts with both the inflammatory and non-inflammatory macrophages in a similar way.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Oregonin, ≥95% (LC/MS-ELSD)